AOD-9604

What is AOD-9604?

AOD-9604 is a synthetic fragment of human growth hormone (hGH) spanning amino acids 176–191 and 16 amino acids long. Its structure was designed to retain the hormone’s putative lipolytic region, but not the regions responsible for growth and other systemic effects.

It is therefore often described as a “metabolism fragment”. It is important to understand that a fragment is not the same as the whole hormone: removing part of the sequence changes binding, stability and the biological response.

What has been studied?

Research has focused on:

• lipolysis in adipocytes (fat cells);
• fatty acid metabolism;
• a possible effect on body composition;
• safety and pharmacokinetics in humans.

Some preclinical studies indicated increased lipolysis, but clinical results are mixed. Randomised studies in humans have not confirmed a consistent, clinically meaningful reduction in body mass. This is crucial: a biological signal in a cell does not yet mean an effect on the scales.

Why are the results mixed?

There are several possible reasons:

1. Dose and duration differ between studies.
2. Body composition depends on many factors, not just one peptide.
3. Pharmacokinetics of the fragment differ from those of the whole hormone.
4. Publication bias — positive results are published more often.

A good study must therefore include a control group, standardised nutrition and measurement of body composition with a validated method, not just body mass.

Safety and regulation

AOD-9604 is not an approved medicine. Data on long-term safety are limited. In sport, growth hormone fragments may be prohibited; check the rules in force.

In addition, it should be noted that any use in humans without approval and professional supervision carries unknown risk.

Quality

The specification declares a purity of ≥ 98 % (HPLC). Because this is a relatively short peptide, correct identification and the absence of related fragments are particularly important. Mass spectrometry helps confirm that the molecule is not a similar but incorrect one.

Storage

Store the lyophilizate at −20 °C, protected from light and moisture. After reconstitution, follow the protocol and store at 2–8 °C.

Conclusion

AOD-9604 is an interesting example of how a promising preclinical hypothesis can fall short of expectations in clinical studies. It remains a research compound, not a verified means of changing body composition.